What is MIR's health score?

Mirion Technologies, Inc. (MIR) has a TradeApes health score of 53 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MIR's estimated fair value?

Based on our 5-year discounted cash flow model, Mirion Technologies, Inc.'s estimated fair value is $2.86 per share, representing a -82.5% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is MIR undervalued or overvalued?

Our model currently rates MIR as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Get live scores & alerts on your phone

📱 Get the App

Create an account for unlimited access

Mirion Technologies, Inc. (MIR)

Healthcare Overvalued low mixed

$16.33

Updated: 2026-07-16

TradeApes Score

Financial Strength

50 Mixed

Operating Trend

50 Mixed

Relative Value

50 Mixed

Capital Allocation

50 Mixed

Risk Management

80 Strong

Est. Fair Value $2.86

DCF Upside -82.5%

Sector Rank #1242 of 12122

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

Industry Related Stocks

AGILENT TECHNOLOGIES, INC. (A) ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Aardvark Therapeutics, Inc. (AARD) AUTOSCOPE TECHNOLOGIES CORP (AATC) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.